QUADRANT CAPITAL GROUP LLC - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 67 filers reported holding AUTOLUS THERAPEUTICS PLC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
QUADRANT CAPITAL GROUP LLC ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$7,046
-2.1%
3,0240.0%0.00%0.0%
Q2 2023$7,198
+1.0%
3,024
-21.9%
0.00%0.0%
Q1 2023$7,129
+341.4%
3,874
+355.8%
0.00%
Q4 2022$1,615
-19.2%
850
-7.7%
0.00%
Q3 2022$2,000
-84.6%
921
-70.2%
0.00%
-100.0%
Q1 2022$13,000
-35.0%
3,087
-19.0%
0.00%0.0%
Q4 2021$20,000
-13.0%
3,813
+10.7%
0.00%
-33.3%
Q3 2021$23,000
+53.3%
3,444
+53.1%
0.00%
+50.0%
Q2 2021$15,0002,2500.00%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q2 2022
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 2,283,966$15,166,0001.40%
Sio Capital Management, LLC 591,870$3,930,0000.98%
TFG Asset Management GP Ltd 2,500,000$16,600,0000.90%
Ikarian Capital, LLC 1,356,048$9,004,0000.73%
SABBY MANAGEMENT, LLC 400,050$2,656,0000.37%
Nantahala Capital Management 1,793,500$11,909,0000.34%
Regency Capital Management Inc.\DE 57,000$378,0000.29%
Eversept Partners, LP 473,074$3,141,2110.21%
MYDA Advisors LLC 85,000$564,0000.14%
Henry James International Management Inc. 54,047$359,0000.10%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders